Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1981 Oct;36(10):752-8.
doi: 10.1136/thx.36.10.752.

Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease

Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease

E Weitzenblum et al. Thorax. 1981 Oct.

Abstract

In 175 patients with chronic obstructive lung disease (157 chronic bronchitic and 18 emphysematous patients) exhibiting moderate to severe airway obstruction (mean FEV1/vital capacity = 40.2 +/- 11.1%), cumulative survival rates calculated by the actuarial method were compared in subgroups according to the initial level of mean pulmonary artery pressure, pulmonary volumes, and arterial blood gases. Patients were catheterised between 1968 and 1972 and were followed for at least five years. The results emphasise the high prognostic value of PAP since survival rates after four and seven years were significantly lower in the subgroup with PAP greater than 20 mmHg (2.7 kPa). Certain other parameters ("driving" pressure across the pulmonary circulation, FEV1 and Paco2) appear to be equally good at predicting survival as PAP in these obstructed patients. The effect of age should be taken into account in prognostic studies such as ours since survival rates were significantly lower in patients over 60 years of age. In 64 patients who underwent a second right heart catheterisation at least three years after the first (average delay: 5.5 +/- 2 years), the prognostic value of changes in PAP, arterial blood gases, and pulmonary volumes was studied but with the exception of Pao2 was unremarkable. Further studies are needed in this field.

PubMed Disclaimer

References

    1. Lancet. 1966 Apr 16;1(7442):830-5 - PubMed
    1. J Appl Physiol. 1966 May;21(3):1108-16 - PubMed
    1. Bull Physiopathol Respir (Nancy). 1972 Jan-Feb;8(1):49-71 - PubMed
    1. Am J Med. 1971 Oct;51(4):504-12 - PubMed
    1. Am Rev Respir Dis. 1973 Dec;108(6):1373-83 - PubMed